Loading…
Infinium Pharmachem (INFINIUM)₹269.95−1.85%Pharmaceuticals
At the end of the Mar 2026 quarter, Infinium Pharmachem's shareholders were: promoters 64.96%, DIIs 0.21%, public 34.83%. Promoter holding is up 5.00 percentage points from 59.96% a quarter earlier. 0.00% of promoter shares were pledged. It had 1,062 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Promoters | 73.10% | 73.10% | 73.10% | 65.29% | 65.29% | 59.96% | 64.96% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.02% | 0.21% |
| Public | 26.90% | 26.90% | 26.90% | 34.71% | 34.71% | 40.02% | 34.83% |
| Promoter shares pledged | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 647 | 772 | 948 | 999 | 959 | 1,053 | 1,062 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Pravin Bhadabhai Madhani | Promoter | 21.64% | — |
| Sanjaykumar Viththalbhai Patel | Promoter | 10.27% | — |
| Lavjibhai Ramjibhai Chikhaliya | Promoter | 7.55% | — |
| Madhani Krunal Pravinbhai | Promoter | 4.98% | — |
| Mitesh Lavjibhai Chikhaliya | Promoter | 4.79% | — |
| Ashish Kacholia | Public | 4.63% | — |
| Ashish Agarwal | Public | 4.61% | — |
| Daxa Sanjaykumar Patel | Promoter | 3.69% | — |
| Bharat Khodabhai Madhani | Promoter | 3.27% | — |
| Varshaben Pravinbhai Madhani | Promoter | 2.34% | — |
| Shardaben Lavjibhai Chikhaliya | Promoter | 1.98% | — |
| Dipen Babulal Dobariya | Public | 1.60% | — |
| Vinitkumar Maheshkumar Dobariya | Public | 1.60% | — |
| Mignesh Lavjibhai Chikhaliya | Promoter | 1.46% | — |
| Piyush Viththalbhai Chikhaliya | Promoter | 0.81% | — |
| Urvishaben Piyushbhai Chikhaliya | Promoter | 0.72% | — |
| Vitthalbhai Ramjibhai Chikhalia | Promoter | 0.43% | — |
| Krupaben Miteshbhai Chikhaliya | Promoter | 0.24% | — |
| Pratikshaben Lavjibhai Chikhaliya | Promoter | 0.24% | — |
| Varsha Virani | Promoter | 0.24% | — |
| Manjulaben Vitthalbhai Chikhalia | Promoter | 0.18% | — |
| Bhadabhai Kacharabhai Madhani | Promoter | 0.00% | — |
Promoters held 64.96% of Infinium Pharmachem at the end of the Mar 2026 quarter, down 8.14 percentage points from 73.10% a year earlier.
In the Mar 2026 quarter, foreign institutional investors (FIIs) held no reported stake and domestic institutions (DIIs) held 0.21% (up 0.19 percentage points from 0.02% a quarter earlier).
No. The Mar 2026 filing shows no pledged promoter shares.
Infinium Pharmachem had 1,062 shareholders at the end of the Mar 2026 quarter, against 948 a year earlier.
Ashish Kacholia (Public) held 4.63% at the end of the Mar 2026 quarter, the largest named holding outside the promoter group.